“We are extremely proud and delighted to announce the growing number of pregnancies and look forward to our first myLotus 'live births' later this year,” said chairman Matthew Walls.
“Whilst our marketing and brand profile are nascent our early pregnancy statistics are impressive. Following the recent myLotus launch our first wave of users are women who have struggled to conceive naturally, some after trying for many years.”
He added: “These women and their testimonials are now providing real world evidence of the value of the myLotus technology as a breakthrough in helping women increase their chances of a natural pregnancy.”
myLotus is an easy-to-use home test that has been developed for women who have been trying to conceive without any luck for at least six months.
It measures hormone levels in urine to identify the woman’s most fertile days and can also help to explain the apparent lack of fertility.
A smartphone app helps users keep track of their results, which can then be shared with doctors to help improve the chances of conception.
The test was launched in the UK at the end of 2018, and a recent tie-up with Boots means it can now be found in the chemist’s stores up and down the country.
Concepta expects to sign more business-to-business deals “over the coming months”, it said today.
In lunchtime trading, shares in Concepta were 4.3% higher at 2.45p.
-- Adds share price --